Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study (Q48023199)

7 February 2018

title

Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study (English)

1 reference

7 February 2018

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

AbdelKader A Metwally

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sherweit H El-Ahmady

1 reference

7 February 2018

publication date

12 October 2017

1 reference

7 February 2018

published in

Natural Product Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

2873-2881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug p

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Bis-demethoxy curcumin analog nanoparticles: synthesis, characterization, and anticancer activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Towards better modelling of drug-loading in solid lipid nanoparticles: Molecular dynamics, docking experiments and Gaussian Processes machine learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Transport of drugs from the nasal cavity to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Is nose-to-brain transport of drugs in man a reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Modulation of Anxiety Behavior by Intranasally Administered Vaccinia Virus Complement Control Protein and Curcumin in a Mouse Model of Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Recent advances in curcumin nanoformulation for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

A Comprehensive Computational Study of the Interaction between Human Serum Albumin and Fullerenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

The effect of curcumin (turmeric) on Alzheimer's disease: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Determination of antiplasmodial activity and binding affinity of curcumin and demethoxycurcumin towards PfTrxR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Computational and experimental approaches for investigating nanoparticle-based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

"Disease modifying nutricals" for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Combinatorial anticancer effects of curcumin and sorafenib towards thyroid cancer cells via PI3K/Akt and ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

From nose to brain: understanding transport capacity and transport rate of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

Evaluating the potential of natural curcumin for oxidative stability of soybean oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786419.2017.1385017

10.1080/14786419.2017.1385017

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29022380%20AND%20SRC:MED&resulttype=core&format=json